Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:20 pm Purchase | 2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management, L.P. | 1,150,648 7.400% | 189,778 (+19.75%) | Filing History |
| 2023-02-14 4:20 pm Purchase | 2022-12-31 | 13G | Eos Energy Enterprises, Inc. EOSE | Point72 Asset Management, L.P. | 5,535,030 6.700% | 2,493,265 (+81.97%) | Filing History |
| 2023-02-14 4:19 pm Sale | 2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | Point72 Asset Management, L.P. | 69,450 0.100% | -1,984,767 (-96.62%) | Filing History |
| 2023-02-14 4:19 pm Sale | 2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Point72 Asset Management, L.P. | 1,178,501 1.900% | -1,828,637 (-60.81%) | Filing History |
| 2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management, L.P. | 1,920,253 3.500% | -864,631 (-31.05%) | Filing History |
| 2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Point72 Asset Management, L.P. | 30,441 1.300% | -23,999 (-44.08%) | Filing History |
| 2023-02-14 4:17 pm Unchanged | 2022-12-31 | 13G | Cepton, Inc. CPTN | Point72 Asset Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:17 pm Sale | 2022-12-31 | 13G | uniQure N.V. QURE | Point72 Asset Management, L.P. | 1,745,461 3.700% | -1,866,230 (-51.67%) | Filing History |
| 2023-02-14 4:16 pm Sale | 2022-12-31 | 13G | TRICIDA INC TCDAQ | Point72 Asset Management, L.P. | 167,509 0.300% | -3,117,394 (-94.90%) | Filing History |
| 2023-02-14 4:15 pm Sale | 2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Point72 Asset Management, L.P. | 30,702 0.100% | -2,037,172 (-98.52%) | Filing History |
| 2023-02-14 4:14 pm Sale | 2022-12-31 | 13G | Tactile Systems Technology, Inc. TCMD | Point72 Asset Management, L.P. | 71,124 0.400% | -1,111,666 (-93.99%) | Filing History |
| 2023-02-14 4:14 pm Sale | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 2,438,138 4.200% | -1,032,140 (-29.74%) | Filing History |
| 2023-02-14 4:13 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Point72 Asset Management, L.P. | 56,207 0.200% | -2,045,830 (-97.33%) | Filing History |
| 2023-02-14 4:13 pm Sale | 2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | Point72 Asset Management, L.P. | 0 0.000% | -6,312,371 (Position Closed) | Filing History |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | Point72 Asset Management, L.P. | 1,299,548 2.000% | -1,817,932 (-58.31%) | Filing History |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | Point72 Asset Management, L.P. | 10,673 0.100% | -1,653,394 (-99.36%) | Filing History |
| 2023-02-14 4:11 pm Sale | 2022-12-31 | 13G | Chimerix, Inc. CMRX | Point72 Asset Management, L.P. | 75,926 0.100% | -4,472,328 (-98.33%) | Filing History |
| 2023-02-14 4:11 pm Sale | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 368,006 0.700% | -2,052,303 (-84.80%) | Filing History |
| 2023-02-14 4:10 pm Sale | 2022-12-31 | 13G | Progress Acquisition Corp. PGRW | Point72 Asset Management, L.P. | 0 0.000% | -870,229 (Position Closed) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,021,168 3.400% | -551,655 (-35.07%) | Filing History |